Cinemark: Cyclical Recovery With Strengthened Balance Sheet

  • I rate Cinemark a buy, as the industry is entering a strong recovery cycle driven by a ramp-up in film supply. Consumer demand for theatrical releases remains resilient, with audiences willing to pay higher prices and attend when compelling content is available. CNK's balance sheet will strengthen post-August 2025 after repaying convertible debt, enabling potential capital returns to shareholders.